Children’s Minnesota testing vaccine against deadly pediatric brain cancer
The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.
Merck stock price target lowered to $95 by Bernstein SocGen
Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...
Barchart on MSN1d
Wall Street Predict 92% Upside for This Dividend Stock: Should You Buy It Now?
Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.
HPV 'cures' are popping up online, but here's the truth about the STI and its vaccine
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...
A leading pediatrician was already worried about the future of vaccines. Then RFK Jr. came along
In a new book, pediatric infectious disease specialist Dr. Adam Ratner details the history of measles, a virus that’s often a ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
University of California5d
Ask an expert: Is H5N9 bird flu a threat to humans?
UC San Francisco's Rais Vohra, MD, explains recent increase in reported virus infections and the risks of consuming raw cow’s ...
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...